// App-Quantinova.ai

3069 : Investigation of pharmacodynamic and predictive biomarkers to define response to proteasome inhibitor marizomib in glioma

Researchers

Presenter

  • Daniela Bota

Principal Investigators

  • Annick Desjardins

  • Warren Mason

  • Kaijun Di

  • Ann P. MacLaren

  • Nancy Levin

  • Mohit Trikha

Medical Centers

  • University of California, Irvine, Fullerton, CA

  • Duke University Medical Center, Durham, NC

  • Princess Margaret Hospital, Toronto, ON, Canada

  • Triphase Accelerator, San Diego, CA

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

  • Solid malignancies

  • Gliomas

Biomarkers

  • N/A

Drug/Treatment

  • Bevacizumab

  • Marizomib

Outcome

  • N/A

Study Design

  • Pharmacodynamics

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved